# Microbial and inflammatory regulation of intestinal epithelial gene transcription

> **NIH NIH P01** · UNIV OF NORTH CAROLINA CHAPEL HILL · 2021 · $365,388

## Abstract

ABSTRACT
There exist fundamental gaps in our understanding of the transcriptional regulatory pathways through which
microbiota and inflammation alter gene expression in the intestinal epithelium, and how those pathways promote
and might predict intestinal homeostasis. Our long-term goal is to understand the evolutionarily-conserved
mechanisms underlying host-microbe interactions in the intestine and how they contribute to human diseases.
The overall objectives of this project are to identify conserved transcriptional regulatory pathways mediating
intestinal epithelial cell (IEC) responses to microbiota and inflammation, and determine if their activity can be
used as phenotypic indicators in human inflammatory bowel disease (IBD). Our preliminary studies in human,
mouse, and zebrafish IECs have uncovered striking conservation of transcriptional signatures and regulatory
mechanisms, predicting central conserved roles for transcription factors (TF) implicated in human IBD including
HNF4A and ELF3. We recently made the key discovery that HNF4A is a novel mediator of IEC transcriptional
responses to microbiota in zebrafish and mice. Mechanistic studies in zebrafish and mice revealed that HNF4A
is a positive regulator of microbially-suppressed genes, and that microbiota broadly suppress HNF4A activity in
IECs. Further, our results show that intestinal suppression of HNF4A target genes is a prevalent feature of
human, mouse, and zebrafish models of IBD, and indicate that HNF4A constrains inflammatory responses to
microbiota and suppresses a conserved IBD-like gene expression signature. Finally, we identified DNA enhancer
elements in mouse IECs that are regulated by microbiota colonization, and leverage those results to implicate
ELF3 as a potential integrator of inflammatory and microbial signals in IECs. We will test the central hypothesis
that microbiota promote intestinal inflammation by coordinately suppressing anti-inflammatory HNF4A activity
and activating ELF3 and other pro-inflammatory transcriptional pathways. In Specific Aim 1, we will identify host
signaling mechanisms mediating microbial suppression of HNF4A activity in IECs. In Specific Aim 2, we will
define the roles of ELF3 and broader transcriptional pathways in IEC responses to microbiota and inflammation,
and test if IBD phenotypes are associated with distinct signatures of ELF3 and HNF4A activity. The expected
outcomes will vertically advance the field in several ways. First, they will generate a foundational mechanistic
understanding of how gut microbes regulate the activity of HNF4A and ELF3, conserved TFs with critical roles
in intestinal inflammation. Second, they will provide much-needed insights into the transcriptional regulatory
networks utilized by IECs to integrate microbial and inflammatory stimuli, and how those networks are deranged
in human IBD. These outcomes are expected to have a significant impact because they will vertically advance
our understanding of the IEC tran...

## Key facts

- **NIH application ID:** 10216243
- **Project number:** 5P01DK094779-08
- **Recipient organization:** UNIV OF NORTH CAROLINA CHAPEL HILL
- **Principal Investigator:** John F Rawls
- **Activity code:** P01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $365,388
- **Award type:** 5
- **Project period:** 2013-09-19 → 2024-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10216243

## Citation

> US National Institutes of Health, RePORTER application 10216243, Microbial and inflammatory regulation of intestinal epithelial gene transcription (5P01DK094779-08). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10216243. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*